Novartis India Ltd.
BSE: 500672 | Sector: Health care |
NSE: NOVARTIND | ISIN Code: INE234A01025 |
BSE 00:00 | 20 May | 588.35 |
-11.30 (-1.88%) |
OPEN
572.25 |
HIGH
599.15 |
LOW
572.25 |
NSE 00:00 | 20 May | 588.15 |
-12.05 (-2.01%) |
OPEN
590.05 |
HIGH
598.00 |
LOW
580.00 |
OPEN | 572.25 |
PREVIOUS CLOSE | 599.65 |
VOLUME | 2776 |
52-Week high | 1099.00 |
52-Week low | 572.25 |
P/E | 31.87 |
Mkt Cap.(Rs cr) | 1,453 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
About Novartis India Ltd.
Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis the world's second largest pharmaceutical company was incorporated on 13 December 1947. The Company is focused on manufacturing and marketing of drugs pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates in four segments such as Pharmaceuticals Generics Over the Trade Counter and Ani...> More
Novartis India Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
1,453 | |
EPS - TTM | (![]() |
[*S] | 18.46 |
P/E Ratio | (X) | [*S] | 31.87 |
Face Value | (![]() |
5 | |
Latest Dividend | (%) | 200.00 | |
Latest Dividend Date | 17 Aug 2021 | ||
Dividend Yield | (%) | 1.70 | |
Book Value / Share | (![]() |
[*S] | 280.15 |
P/B Ratio | (![]() |
[*S] | 2.10 |
Announcement
-
Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
The Register Of Members And Share Transfer Books Shall Be Closed From Friday July 22 2022 To Friday
-
Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited (The Company) Held On May
-
Board Meeting Outcome for Outcome Of The Meeting Of The Board Of Directors Of Novartis India Limited
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure
Novartis India Ltd - Financial Results
Particulars (![]() |
Mar 2022 | Mar 2021 | % Chg |
Net Sales | 98.32 | 99.29 | -0.98 |
Other Income | 14.31 | 12.27 | 16.63 |
Total Income | 112.63 | 111.56 | 0.96 |
Total Expenses | 142.34 | 84.02 | 69.41 |
Operating Profit | -29.71 | 27.54 | -207.88 |
Net Profit | -23.37 | 9.7 | -340.93 |
Equity Capital | 12.34 | 12.34 | - |
Novartis India Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
Alembic | 70.00 | 0.43 | 1797.60 |
Unichem Labs. | 241.65 | 3.36 | 1701.22 |
Solara Active | 430.40 | 0.40 | 1549.44 |
Novartis India | 588.35 | -1.88 | 1453.22 |
Neuland Labs. | 1026.75 | 0.27 | 1317.32 |
Orchid Pharma | 311.00 | 3.24 | 1269.50 |
NGL Fine Chem | 1959.80 | 0.46 | 1211.16 |
Novartis India Ltd - SHAREHOLDING PATTERN
|
|
Novartis India Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 0.41% | 0.20% | 2.90% | 3.07% |
1 Month | -7.64% | -7.47% | -4.75% | -5.08% |
3 Month | -16.37% | -16.40% | -6.06% | -5.85% |
6 Month | -25.51% | -25.46% | -8.90% | -8.44% |
1 Year | -6.07% | -6.11% | 9.61% | 9.12% |
3 Year | -14.65% | NA | 38.05% | 37.52% |
Novartis India Ltd - STOCK STRENGTH
Today's Low/High | 572.25 | 599.15 | |
Week Low/High | 572.25 | 620.00 | |
Month Low/High | 572.25 | 655.00 | |
YEAR Low/High | 572.25 | 1099.00 | |
All TIME Low/High | 22.17 | 1436.00 |
Quick Links for Novartis India:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices